{
    "nctId": "NCT04883398",
    "briefTitle": "A Study of Attention and Memory Processes in Breast Cancer Survivors",
    "officialTitle": "Neural and Cognitive Mechanisms of Attention and Memory Deficits in Cancer Survivors",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer Survivors",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 65,
    "primaryOutcomeMeasure": "test early attentional deficits",
    "eligibilityCriteria": "Inclusion Criteria:\n\nFor All Paricipants:\n\n* As per medical record or self-report, female\n* As per medical record or self-report, age 50-70\n* Score of \\< 11 on the Blessed Orientation-Memory-Concentration Test (BOMC)\n* English fluent (as per self reported fluency of \"well\" or \"very well\", and having a reasonable comprehension of the study conversation in the opinion of the research staff/preference of English language for healthcare)\\*\\*\n* As per medical record or self-report, if currently taking psychoactive medications (excluding gabapentin and including but not limited to antidepressants and anxiolytics) on a daily basis, dose must have been stable at least two months prior to enrollment\n\nFor Survivors:\n\n* As per medical record or self-report, AJCC stages 0-3 breast cancer\n* As per medical record or self-report, at least 1-year post-treatment for breast cancer (including surgery, and chemotherapy, with or without radiation\n* As per medical record or self-report, current endocrine therapy\n\nFor Healthy Controls:\n\n* As per self-report, if currently taking psychoactive medications (including but not limited to antidepressants and anxiolytics), dose must have been stable at least two months prior to enrollment.\n* As per self report, no history of cancer except non-melanoma/basal cell skin cancer/squamous cell skin carcinoma\n\nExclusion Criteria:\n\nFor All Participants:\n\n* As per medical record or self-report, diagnosis of neurodegenerative disorder that affects cognitive function (e.g. Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Dementia, Seizure Disorders, etc.)\n* As per medical record or self report, history of stroke or head injury resulting in a structural lesion on neuropsych imaging, persistent cognitive difficulties impacting work or daily life, or required cognitive rehabilitation\n* As per medical record or self report, a diagnosis of a Schizophrenia Spectrum Disorder, substance use disorder, Bipolar Disorder or Schizotypal personality disorder. Schizophrenia Spectrum Disorders include Schizophrenia, Schizophreniform disorder, Schizoaffective disorder, Delusional disorder, Brief psychotic disorder, and Attenuated Psychotic Disorder\n* As per medical record or self-report, visual or auditory impairment that would preclude ability to complete the assessments (e.g. history of significant macular degeneration or being unable to correct hearing with hearing aides)\n* As per medical record or self-report, use of methotrexate (Amethopterin, Rhematrex, Trexall) or rituximab (Rituxin) for rheumatoid arthritis, psoriasis or Crohn's disease, or cyclophosphamide (Cytoxan, Neosar) for Lupus\n* As per medical record or self-report, participation in a conflicting research study (i.e. another neurocognitive study utilizing HVLT and BVMT tasks.)\n\nFor Survivors only:\n\n* As per medical record or self-report, history of another type of cancer or prior breast cancer diagnosis except non-melanoma/basal cell skin cancer/squamous cell skin carcinoma\n* As per medical record or self-report, disease recurrence.\n\nFor Healthy Controls only:\n\n* As per medical record or self-report, history of treatment using radiation, chemotherapy, and/or Tamoxifen or Aromatase-inhibitors",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}